Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Income towards Parent Company (2016 - 2025)

Anaptysbio (ANAB) has disclosed Income towards Parent Company for 10 consecutive years, with $49.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company rose 327.75% year-over-year to $49.6 million, compared with a TTM value of -$13.2 million through Dec 2025, up 90.89%, and an annual FY2025 reading of -$13.2 million, up 90.89% over the prior year.
  • Income towards Parent Company was $49.6 million for Q4 2025 at Anaptysbio, up from $15.1 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $49.6 million in Q4 2025 and bottomed at -$46.7 million in Q2 2024.
  • Average Income towards Parent Company over 5 years is -$23.9 million, with a median of -$31.2 million recorded in 2021.
  • The sharpest move saw Income towards Parent Company crashed 6121.91% in 2022, then surged 327.75% in 2025.
  • Year by year, Income towards Parent Company stood at -$31.1 million in 2021, then rose by 28.8% to -$22.1 million in 2022, then crashed by 90.51% to -$42.2 million in 2023, then soared by 48.34% to -$21.8 million in 2024, then soared by 327.75% to $49.6 million in 2025.
  • Business Quant data shows Income towards Parent Company for ANAB at $49.6 million in Q4 2025, $15.1 million in Q3 2025, and -$38.6 million in Q2 2025.